Covered recipient · General Payments record
MARIA S RAYAS
Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology
General Payments · PY2018–2024
$1,129.82
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $323.41 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $135.12 | 2 |
| Abbott Laboratories | $79.27 | 4 |
| Ascendis Pharma Inc | $40.39 | 2 |
| BAXTER HEALTHCARE | $18.97 | 1 |
| IBSA Pharma Inc. | $17.84 | 1 |
| Insulet Corporation | $17.61 | 1 |
| Azurity Pharmaceuticals, Inc. | $14.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.25 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125075344 | CMS |
| Abbott Laboratories | $18.90 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125075346 | CMS |
| Abbott Laboratories | $24.87 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125075348 | CMS |
| Abbott Laboratories | $18.25 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125075350 | CMS |
| Ascendis Pharma Inc | $21.18 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133846205 | CMS |
| Ascendis Pharma Inc | $19.21 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133848870 | CMS |
| Azurity Pharmaceuticals, Inc. | $14.21 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134011529 | CMS |
| Baxter Healthcare | $18.97 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120666636 | CMS |
| IBSA Pharma Inc. | $17.84 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142985492 | CMS |
| Insulet Corporation | $17.61 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116808371 | CMS |
| Novo Nordisk Inc | $110.20 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097806944 | CMS |
| Novo Nordisk Inc | $24.92 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096902661 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.